Mu-Opiod receptor splice variant polypeptides

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007100, C435S007200

Reexamination Certificate

active

07087714

ABSTRACT:
The present invention encompasses novel splice variant forms of the mu-opioid receptor-1 (MOR-1) and the polynucleotide sequences encoding the MOR-1 splice variants. The invention further encompasses methods of screening for compositions regulating the MOR-1 splice variant activities and the development of therapeutic modalities directed to regulating activity. Regulation of the MOR-1 splice variant activities may impact the physiologic process of analgesia.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 6103492 (2000-08-01), Yu
Abbadie et al. (1999) “Neurons in the dorsal column white matter of the spinal cord: complex neuropilin an unexpected location” Proc. Natl. Acad. Sci. USA 96:260-265.
Bare et al. (1994) “Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain” FEBS Lett. 354:213-6.
Chen et al. (1993)“Molecular cloning and functional expression of a μ-opioid receptor from rat brain” Mol. Pharmacol. 44:8-12.
Cole et al. (1985) “Monoclonal Antibodies and Cancer Therapy” Alan R. Liss, Inc., pp. 77-96.
Cote et al. (1983) “Generation of human monoclonal antibodies reactive with cellular antigens” Proc. Natl. Acad. Sci. USA 80:2026-2030.
Delfs et al. (1994) “Expression of μ opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level”0 J. Comp. Neurol. 345:46-68.
Elliott et al. (1994) “The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the μ-opioid morphine but not to κ opioids” Pain 56:69-75.
Evans et al. (1981) “Establishment in culture of pluripotential cells from mouse embryos” Nature 292:154-6.
Giros et al. (1995) “Chromosomal localization of opioid peptide and receptor genes in the mouse” Life Sci. 56:369-375.
Guiramand et al. (1995) “Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins” J. Biol. Chem. 270:7354-58.
Huse et al. (1999) “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda” Science 246:1275-81.
Kolesnikov et al. (1994) “1-Aminocyclopropane carboxylic acid (ACPC) prevents μ and δ opioid tolerance” Life Sci. 55:1393-98.
Kolesnikov et al. (1993) “Blockade of tolerance to morphine but not to κ opioids by a nitric oxide synthase inhibitor” Proc. Natl. Acad. Sci. USA 90:5162-5166.
Liang et al. (1995) “Cloning and characterization of the promoter region of the mouse μ opioid receptor gene” Brain Res. 679:82-88.
Lowry et al. (1951) “Protein measurement with the folin phenol reagent” J. Biol. Chem. 193:265-75.
Lucas et al. (1995) “New players in the 5-HT receptor field: genes and knockouts” TiPS 16:246-252.
Lutz et al. (1992) “Opioid receptors and their pharmacological profiles” J. Receptor Res. 12:267-286.
Min et al. (1994) “Genomic Structure analysis of promoter sequence of a mouse μ opioid receptor gene” Proc. Natl. Acad. Sci. USA 91:9081-85.
Morrison et al. (1984) “Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains” Proc. Natl. Acad. Sci. USA 81:6851-55.
Neuberger et al. (1984) “Recombinant antibodies possessing novel effector functions” Nature 312:604-8.
Olson et al. (1989) “Endogenous opiates: 1988” Peptides 10:1253-1280.
Pan et al. (1994) “Cloning, Expression and Classification of a κ3—Related opioid receptor using Antisense Oligodeoxynucleotides” Regul. Pept. 54:217-218.
Pan et al. (1996) “Dissociation of affinity and efficacy in KOR-3 chimeras” FEBS Lett. 395:207-10.
Pasternak (1993) “Pharmacological mechanisms of opioid analgesics” Clin. Neuropharmacol. 16:1-18.
Pasternak et al. (1995) “Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology” TiPS 16:344-50.
Reisine et al. (1993) “Molecular Biology of opioid receptors” Trends Neurosci. 16:506-510.
Reisine et al. (1996) “Opioid analgesics and antagonists” in Goodman & Gilman's “The pharmacological basis of therapeutics” 9th Ed. (Harman et al. eds) McGraw-Hill pp. 521-555.
Robertson (1991) “Using embryonic stem cells to introduce mutations into the mouse germ line” Biol. Reprod. 44:238-245.
Rossi et al. (1997) “Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception” J. Pharmacol. Exp. Ther. 281:109-114.
Rossi et al. (1996) “Naloxone sensitive orphanin FQ-induced analgesia in mice”Eur. J. Pharmacol. 311:R7-8.
Rossi et al. (1995) “Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor” FEBS Lett. 369:192-196.
Sibinga et al. (1988) “Opioid peptides and opioid receptors in cells of the immune system” Annu. Rev. Immunol. 6:219-49.
Simon (1991) “Opioid receptors and endogenous opioid peptides” Medicinal Res. Rev. 11:357-374.
Standifer et al. (1997) “G proteins and opioid receptor-mediated signaling” Cell. Signal. 9:237-248.
Standifer et al. (1996) “Differential blockade of opioid analgesia by antisense oligodeoxy-nucleotides directed against various G protein α subunits” Mol. Pharmacol. 50:293-298.
Takeda et al. (1985) “Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences” Nature 314:452-4.
Trujillo et al. (1991) “Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801” Science 251:85-87.
van den Engh et al. (1992) “Estimating genomic distance from DNA sequence location in cell nuclei by a random walk model” Science 257:1410-1412.
Vanetti et al. (1992) “Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)” FEBS Lett. 311:290-294.
Wang et al. (1993) “μopiate receptor: cDNA cloning and expression” Proc. Natl. Acad. Sci. USA 90:10230-34.
Wolozin et al. (1981) “Classification of multiple morphine and enkephalin binding sites in the central nervous system” Proc. Natl. Acad. Sci. USA 78:6181-84.
Yasuda et al. (1993) “Cloning and functional comparison of κ and δ opioid receptors from mouse brain” Proc. Natl. Acad. Sci. USA 90:6736-6740.
Zimprich et al. (1995) “Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B ) which differs in agonist induced desensitization from rMOR1” FEBS Lett. 359:142-146.
Du et al. (1996) “Identification of a novel splice variant of the mouse mu opioid receptor” Soc. Neurosci. Ab 22:695.5.
Du et al. (1997) “A splice variant of the mu opioid receptor is present in human SHSY-5Y cells” Soc. Neurosci. Ab. 23:479.3.
Leventhal et al. (1997) “Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO” J. Pharmacol. Exp. Ther. 282:1402-1407.
Leventhal et al. (1996) “Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats” Brain Res. 719:78-84.
Kaufman, D., et al. J. Biol. Chem 270:15877-15883 (1995).
Rossi et al. (1996) Neurosci. Lett. 216:1-4.
Rossi et al. (1994) Life Sci. 54:375-379.
Pan, Y.-X. GenBank Acession #U26915, Submitted May 11, 1995, FEBS Lett. 369 (2-3), 192-196 (1995).
Pan, Ying-Xian, et al., “Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X”,Science Direct, Biochemical and Biophysical Research Communications 301 (2003) 1057-106

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mu-Opiod receptor splice variant polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mu-Opiod receptor splice variant polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mu-Opiod receptor splice variant polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3711458

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.